Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9466 |
High Similarity |
NPD1240 |
Approved |
0.9328 |
High Similarity |
NPD1510 |
Phase 2 |
0.9323 |
High Similarity |
NPD1607 |
Approved |
0.9007 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8986 |
High Similarity |
NPD1549 |
Phase 2 |
0.8913 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8913 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8841 |
High Similarity |
NPD2796 |
Approved |
0.8741 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8716 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8714 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8699 |
High Similarity |
NPD4380 |
Phase 2 |
0.8571 |
High Similarity |
NPD2935 |
Discontinued |
0.8542 |
High Similarity |
NPD6799 |
Approved |
0.8523 |
High Similarity |
NPD7819 |
Suspended |
0.8523 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8514 |
High Similarity |
NPD7411 |
Suspended |
0.8489 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8477 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8456 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8446 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8444 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8414 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8411 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.84 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD2801 |
Approved |
0.838 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8369 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8355 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD943 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8299 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8289 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8269 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8239 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8217 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8201 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8148 |
Intermediate Similarity |
NPD3972 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8108 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8108 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8108 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8102 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8077 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8013 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7937 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7929 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7895 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7891 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7883 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7881 |
Intermediate Similarity |
NPD920 |
Approved |
0.7881 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7852 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD2797 |
Approved |
0.784 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7821 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.781 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD5401 |
Approved |
0.774 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7683 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7662 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7647 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.759 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7589 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7589 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7569 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7554 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7534 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7534 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD411 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7414 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD17 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7293 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7293 |
Intermediate Similarity |
NPD74 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2403 |
Approved |
0.726 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7247 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD940 |
Approved |
0.7231 |
Intermediate Similarity |
NPD846 |
Approved |
0.7225 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7218 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7218 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7218 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD37 |
Approved |
0.7183 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7175 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7133 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7114
|
Intermediate Similarity |
NPD4060 |
Phase 1 |